A10BD29 • sitagliptin + dapagliflozin • Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Combinations of oral blood glucose lowering drugs
Substance: sitagliptin + dapagliflozin
Date of last drug list: 01-09-2025
Commercial code: W71243026
Concentration: 100mg / 10mg
Pharmaceutical form: tablets
Quantity: 14
Product type: generic
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Manufacturer: KRKA, D.D., NOVO MESTO - SLOVENIA
Holder: KRKA, D.D., NOVO MESTO - SLOVENIA
Number: 16116/2025/26
Shelf life: 2 years